Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to assess the safety, tolerability and toxicity of preoperative HBOT in patients undergoing a pancreaticoduodenal resection for premalignant and malignant tumors...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Florida Hospital Tampa Bay Division
NCT04780256 · Endoscopic Mucosal Resection, Endoscopic Submucosal Dissection, and more
NCT06630910 · Periampullary Carcinoma Resectable, Pancreatic Tumors, and more
NCT07161869 · Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma (Icc), and more
NCT02381249 · Esophageal Neoplasms, Stomach Neoplasms, and more
NCT05688020 · Gastric Polyp, Gastric Neoplasm, and more
Florida Hospital Tampa
Tampa, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions